
4G Clinical Stock
We are equipped to answer the extreme cost and time pressures of clinical trials unlike anyone else.
Sign up today and learn more about 4G Clinical Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About 4G Clinical Stock
We reduce the time it takes to commercialize vital medications by delivering validated, easily extended RTSM capabilities faster than anyone in the world.
Funding History
January 2016 | $2.5M |
---|---|
October 2016 | $5.0M |
Management
COO
Christine Hurley
Co-Founder & CTO
Ed Tourtellotte
Co-Founder & CEO
David Kelleher
Head of Engineering
Cedric Druck
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase